These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 22927437)
1. Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. Ferreras C; Rushton G; Cole CL; Babur M; Telfer BA; van Kuppevelt TH; Gardiner JM; Williams KJ; Jayson GC; Avizienyte E J Biol Chem; 2012 Oct; 287(43):36132-46. PubMed ID: 22927437 [TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling. Cole CL; Rushton G; Jayson GC; Avizienyte E J Biol Chem; 2014 Apr; 289(15):10488-10501. PubMed ID: 24563483 [TBL] [Abstract][Full Text] [Related]
3. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174 [TBL] [Abstract][Full Text] [Related]
4. Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. Baljinnyam E; Umemura M; Chuang C; De Lorenzo MS; Iwatsubo M; Chen S; Goydos JS; Ishikawa Y; Whitelock JM; Iwatsubo K Pigment Cell Melanoma Res; 2014 Jul; 27(4):611-20. PubMed ID: 24725364 [TBL] [Abstract][Full Text] [Related]
5. Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo. Avizienyte E; Cole CL; Rushton G; Miller GJ; Bugatti A; Presta M; Gardiner JM; Jayson GC PLoS One; 2016; 11(8):e0159739. PubMed ID: 27490176 [TBL] [Abstract][Full Text] [Related]
6. 2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline. Chan WK; Howe K; Clegg JM; Guimond SE; Price DJ; Turnbull JE; Pratt T PLoS One; 2015; 10(6):e0130147. PubMed ID: 26075383 [TBL] [Abstract][Full Text] [Related]
7. Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites. Li J; Shworak NW; Simons M J Cell Sci; 2002 May; 115(Pt 9):1951-9. PubMed ID: 11956326 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. Leali D; Belleri M; Urbinati C; Coltrini D; Oreste P; Zoppetti G; Ribatti D; Rusnati M; Presta M J Biol Chem; 2001 Oct; 276(41):37900-8. PubMed ID: 11473122 [TBL] [Abstract][Full Text] [Related]
18. A collagen Vα1-derived fragment inhibits FGF-2 induced-angiogenesis by modulating endothelial cells plasticity through its heparin-binding site. Jia T; Vaganay E; Carpentier G; Coudert P; Guzman-Gonzales V; Manuel R; Eymin B; Coll JL; Ruggiero F Matrix Biol; 2020 Dec; 94():18-30. PubMed ID: 32682018 [TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains. Zhang W; Swanson R; Xiong Y; Richard B; Olson ST J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907 [TBL] [Abstract][Full Text] [Related]